Combination of Low-Dose Gemcitabine and Recombinant Quail Vascular Endothelial Growth Factor Receptor-2 as a Vaccine Induces Synergistic Antitumor Activities

Publisher: Karger

E-ISSN: 1423-0232|69|1|81-87

ISSN: 0030-2414

Source: Oncology, Vol.69, Iss.1, 2005-09, pp. : 81-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract